77 related articles for article (PubMed ID: 8874584)
1. Pharmacokinetic evaluation of omeprazole suspension following oral administration in rats: effect of neutralization of gastric acid.
Watanabe K; Matsuka N; Furuno K; Eto K; Kawasaki H; Gomita Y
Acta Med Okayama; 1996 Aug; 50(4):219-22. PubMed ID: 8874584
[TBL] [Abstract][Full Text] [Related]
2. Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
Johnson CE; Cober MP; Ludwig JL
Ann Pharmacother; 2007 Dec; 41(12):1954-61. PubMed ID: 17956960
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole: pharmacokinetics and metabolism in man.
Cederberg C; Andersson T; Skånberg I
Scand J Gastroenterol Suppl; 1989; 166():33-40; discussion 41-2. PubMed ID: 2690330
[TBL] [Abstract][Full Text] [Related]
4. The effect of changes in gastric pH induced by omeprazole on the absorption and respiratory depression of methadone.
de Castro J; Aguirre C; Rodríguez-Sasiaín JM; Gómez E; Garrido MJ; Calvo R
Biopharm Drug Dispos; 1996 Oct; 17(7):551-63. PubMed ID: 8894114
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05.
Drugs R D; 2004; 5(6):349-50. PubMed ID: 15563239
[TBL] [Abstract][Full Text] [Related]
6. Oral pharmacokinetics of omeprazole.
Howden CW; Meredith PA; Forrest JA; Reid JL
Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intrarectal omeprazole in alpacas.
Marmulak T; Stanley S; Kass PH; Wiebe V; McKemie D; Pusterla N
J Vet Pharmacol Ther; 2010 Aug; 33(4):371-5. PubMed ID: 20646199
[TBL] [Abstract][Full Text] [Related]
8. The effect of immobilization stress on the pharmacokinetics of omeprazole in rats.
Watanabe K; Matsuka N; Okazaki M; Hashimoto Y; Araki H; Gomita Y
Acta Med Okayama; 2002 Feb; 56(1):19-23. PubMed ID: 11873940
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Comparison of Omeprazole Granule and Suspension Forms in Children: A Randomized, Parallel Pilot Trial.
Karami S; Dehghanzadeh G; Haghighat M; Mirzaei R; Rahimi HR
Drug Res (Stuttg); 2016 Mar; 66(3):165-8. PubMed ID: 26398674
[TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole on gastric acid secretion in rat: evaluation of dose, duration of effect, and route of administration.
Segawa K; Nakazawa S; Tsukamoto Y; Chujoh C; Yamao K; Hase S
Gastroenterol Jpn; 1987 Aug; 22(4):413-8. PubMed ID: 3666382
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
12. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.
Howden CW; Forrest JA; Meredith PA; Reid JL
Br J Clin Pharmacol; 1985 Aug; 20(2):137-9. PubMed ID: 3929808
[TBL] [Abstract][Full Text] [Related]
13. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
Mohiuddin MA; Pursnani KG; Katzka DA; Gideon RM; Castell JA; Castell DO
Dig Dis Sci; 1997 Apr; 42(4):715-9. PubMed ID: 9125637
[TBL] [Abstract][Full Text] [Related]
14. [Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].
Soifer L; Peralta AD; Arenoso H; Caruso N; Naisberg G
Acta Gastroenterol Latinoam; 2009 Dec; 39(4):261-6. PubMed ID: 20178255
[TBL] [Abstract][Full Text] [Related]
15. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral omeprazole in llamas.
Poulsen KP; Smith GW; Davis JL; Papich MG
J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
[TBL] [Abstract][Full Text] [Related]
17. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.
Andersson T; Andrén K; Cederberg C; Lagerström PO; Lundborg P; Skånberg I
Br J Clin Pharmacol; 1990 May; 29(5):557-63. PubMed ID: 2350532
[TBL] [Abstract][Full Text] [Related]
19. Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation.
Lee DY; Lee I; Lee MG
JPEN J Parenter Enteral Nutr; 2007; 31(1):37-46. PubMed ID: 17202439
[TBL] [Abstract][Full Text] [Related]
20. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
